Yep. Seems like a lot of people here are either too jaded from being burned in the past or haven't heard of a run-up to a major catalyst. This run-up took longer than most and now it's time, particularly given the October catalyst could mean the company has a $700 million/year drug on its hands. That won't go unnoticed by traders, like myself.
The run up is in direct response to the SA article...nothing more...nothing less. The press release from earnings was out before the market opened that day. There has been no real news. matter of fact, the SA article was dated Aug 1, 12:22 PM. The stock started trickling up between 11-12:00 that same day. Though I believe in Z-160, I also think that as the volume dries up (which it has substantially done already) we will probably see a slow trickle down over the next month or so. If the gap is closed, expect it to drop to $0.58.
Look to this as a time to buy in.